25 June 2020: Clinical Research
Serum Amyloid A: A Potential Biomarker Assessing Disease Activity in Systemic Lupus Erythematosus
Cai-Mei Wang EFG , Jin-Huan Deng EFG , Guo-Fei Mao B , Yong-Ling He B , Xiang Shi AC*DOI: 10.12659/MSM.923290
Med Sci Monit 2020; 26:e923290
Figure 3 The receiver operating characteristics (ROC) curve analysis of serum amyloid A (SAA) to identify patients with active systemic lupus erythematosus (SLE). The sensitivity of SAA levels for the detection of the activity of SLE was 90.4%, and the specificity was 94.0%, with the area under the ROC curve (AUC) of 0.971(95% CI, 0.926–0.992; p<0.001).